Skip to content

TAURIGA SCIENCES, INC.

company.status.inactive

CIK 1142790fmd_1WA3WH95R14783774BYN24QYDRManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard

Coverage: Apr 01, 2010 to Dec 31, 2021, 47 periods

Latest annual · FY2021

Millions
Total revenues
0
Gross profit
0
Operating income
(3)
Net income
(4)
Free cash flow
(3)

Latest quarter · Q3 FY2022

Millions
Total revenues
0
Gross profit
0
Operating income
(1)
Net income
(2)
Free cash flow
(0)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2018 to FY2021
+521.6%
Revenue, 5 yearsFY2016 to FY2021
n/m
Net income, 5 yearsFY2016 to FY2021
n/m

TAURIGA SCIENCES, INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2021FY2020ChangeSource
Revenue$285,319$234,389+21.7%10-K 2021-06-29 · proof
Gross profit$122,692$54,235+126.2%10-K 2021-06-29 · proof
Operating income-$3.4 million-$2 million10-K 2021-06-29 · proof
Net income-$3.6 million-$3 million10-K 2021-06-29 · proof
Cash from operating activities-$2.6 million-$1.5 million10-K 2021-06-29 · proof
Free cash flow-$2.6 million-$1.5 million10-K 2021-06-29 · proof
Total assets$2.5 million$643,462+286.8%10-K 2021-06-29 · proof
Total liabilities$1.2 million$951,659+27.9%10-Q 2021-11-15 · proof
Cash and cash equivalents$49,826$5,348+831.7%10-K 2021-06-29 · proof
What was TAURIGA SCIENCES, INC.'s revenue in fiscal 2021?
TAURIGA SCIENCES, INC. reported revenue of $285,319 for fiscal 2021 (the year ended Mar 31, 2021), against $234,389 the year before (+21.7%). Source: the 10-K filed with the SEC on Jun 29, 2021. SEC
What was TAURIGA SCIENCES, INC.'s gross profit in fiscal 2021?
TAURIGA SCIENCES, INC. reported gross profit of $122,692 for fiscal 2021 (the year ended Mar 31, 2021), against $54,235 the year before (+126.2%). Source: the 10-K filed with the SEC on Jun 29, 2021. SEC
What was TAURIGA SCIENCES, INC.'s operating income in fiscal 2021?
TAURIGA SCIENCES, INC. reported operating income of -$3.4 million for fiscal 2021 (the year ended Mar 31, 2021), against -$2 million the year before. Source: the 10-K filed with the SEC on Jun 29, 2021. SEC
What was TAURIGA SCIENCES, INC.'s net income in fiscal 2021?
TAURIGA SCIENCES, INC. reported net income of -$3.6 million for fiscal 2021 (the year ended Mar 31, 2021), against -$3 million the year before. Source: the 10-K filed with the SEC on Jun 29, 2021. SEC
What was TAURIGA SCIENCES, INC.'s cash from operating activities in fiscal 2021?
TAURIGA SCIENCES, INC. reported cash from operating activities of -$2.6 million for fiscal 2021 (the year ended Mar 31, 2021), against -$1.5 million the year before. Source: the 10-K filed with the SEC on Jun 29, 2021. SEC
What was TAURIGA SCIENCES, INC.'s free cash flow in fiscal 2021?
TAURIGA SCIENCES, INC. reported free cash flow of -$2.6 million for fiscal 2021 (the year ended Mar 31, 2021), against -$1.5 million the year before. Source: the 10-K filed with the SEC on Jun 29, 2021. SEC
What are TAURIGA SCIENCES, INC.'s total assets?
As of Mar 31, 2021, TAURIGA SCIENCES, INC. reported total assets of $2.5 million, against $643,462 a year earlier (+286.8%). Source: the 10-K filed with the SEC on Jun 29, 2021. SEC
What are TAURIGA SCIENCES, INC.'s total liabilities?
As of Mar 31, 2021, TAURIGA SCIENCES, INC. reported total liabilities of $1.2 million, against $951,659 a year earlier (+27.9%). Source: the 10-Q filed with the SEC on Nov 15, 2021 (restated). SEC
What are TAURIGA SCIENCES, INC.'s cash and cash equivalents?
As of Mar 31, 2021, TAURIGA SCIENCES, INC. reported cash and cash equivalents of $49,826, against $5,348 a year earlier (+831.7%). Source: the 10-K filed with the SEC on Jun 29, 2021. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1142790&period_type=annual&limit=5"

Information only, not investment advice.